Search
Search
About
Log in
Join
Experiences with
Fingolimod
Posts
Communities
11 public posts
Filter results
Medicare Part D and Gilenya
Instead they are only covering its generic form,
fingolimod
. Have any of you transitioned from Gilenya to
fingolimod
and if so, how are you doing and how do you feel? Has it produced any untoward reactions? Would love your feedback. Thank you all and be well.
Instead they are only covering its generic form,
fingolimod
. Have any of you transitioned from Gilenya to
fingolimod
and if so, how are you doing and how do you feel? Has it produced any untoward reactions? Would love your feedback. Thank you all and be well.
Flowers17
in
My MSAA Community
6 months ago
PPMS...
Standard FDA-approved medications for MS (for example interferons, glatiramer acetate,
fingolimod
) have not been proven useful in slowing the progression of PPMS. Ocrelizumab is the first FDA-approved medicine for primary progressive MS. It appears to slow the progression of disability.
Standard FDA-approved medications for MS (for example interferons, glatiramer acetate,
fingolimod
) have not been proven useful in slowing the progression of PPMS. Ocrelizumab is the first FDA-approved medicine for primary progressive MS. It appears to slow the progression of disability.
Jesmcd2
CommunityAmbassador
in
My MSAA Community
1 year ago
Antiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights & Diagnostic . .
Front Cell Neurosci. 2019; 13: 107.
Published online 2019 Mar 19. doi: 10.3389/fncel.2019.00107 A
ntiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights and Diagnostic Challenges
Chiara D’Angelo,1,2,3 Oriol Franch,4 Lidia
Front Cell Neurosci. 2019; 13: 107.
Published online 2019 Mar 19. doi: 10.3389/fncel.2019.00107 A
ntiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights and Diagnostic Challenges
Chiara D’Angelo,1,2,3 Oriol Franch,4 Lidia
lupus-support1
Administrator
in
LUpus Patients Understanding and Support
4 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
MSAA News Update - FDA Approves Generic Versions of Gilenya®
In case you didn't see the recent news, I wanted to share MSAA's news article about FDA approval for the first generic versions of Gilenya® (
fingolimod
) oral capsules for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients - here is the full link from the website: https://mymsaa.org
In case you didn't see the recent news, I wanted to share MSAA's news article about FDA approval for the first generic versions of Gilenya® (
fingolimod
) oral capsules for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients - here is the full link from the website: https://mymsaa.org
johnMSAA
Partner
in
My MSAA Community
4 years ago
Vaccines FYI
Some MS therapies, including steroids and disease-modifying therapies like Lemtrada (alemtuzumab), Tysabri (natalizumab), and Gilenya (
fingolimod
), are associated with diminished effectiveness of vaccines and a risk of infection as well.
Some MS therapies, including steroids and disease-modifying therapies like Lemtrada (alemtuzumab), Tysabri (natalizumab), and Gilenya (
fingolimod
), are associated with diminished effectiveness of vaccines and a risk of infection as well.
sashaming1
in
My MSAA Community
5 years ago
FDA Warns of Possible Dangers of Stopping Gilenya
More on the website: https://multiplesclerosisnewstoday.com/2018/11/27/relapsing-ms-fda-warns-possible-dangers-stopping-gilenya-
fingolimod
/
More on the website: https://multiplesclerosisnewstoday.com/2018/11/27/relapsing-ms-fda-warns-possible-dangers-stopping-gilenya-
fingolimod
/
bxrmom
in
My MSAA Community
5 years ago
"What's New in MS Research" - The Latest from MSAA
Fingolimod
versus interferon beta 1-a in pediatric MS 3. Lifetime sun exposure and associates with MS 4. Group cognitive-rehabilitation therapy in MS Plus more!
Fingolimod
versus interferon beta 1-a in pediatric MS 3. Lifetime sun exposure and associates with MS 4. Group cognitive-rehabilitation therapy in MS Plus more!
MSAA_Staff
in
My MSAA Community
6 years ago
My introduction
Been on Copaxone, Rebif, then began in the clinical trial for
Fingolimod
... Began taking Gilenya (aka
Fingolimod
) as soon as it was approved by FDA for release.
Been on Copaxone, Rebif, then began in the clinical trial for
Fingolimod
... Began taking Gilenya (aka
Fingolimod
) as soon as it was approved by FDA for release.
Shannondixon
in
My MSAA Community
6 years ago
I'm a volunteer!
At the time, I was still on the open-label portion of the
Fingolimod
trial. I found a neurologist that was at the same stage in the trial, in San Francisco UCSF . It was an hour's drive, but doable.
At the time, I was still on the open-label portion of the
Fingolimod
trial. I found a neurologist that was at the same stage in the trial, in San Francisco UCSF . It was an hour's drive, but doable.
LeannEHl
in
My MSAA Community
6 years ago
FDA Expands Use of Gilenya® (fingolimod) for Children and Teens 10 Years and Older with Relapsing MS - First Approved Therapy for Pediatric
Food and Drug Administration has approved the expansion of the use of the oral MS therapy Gilenya® (
fingolimod
, Novartis AG) to include the treatment of children and adolescents 10 years of age or older with relapsing MS.
Food and Drug Administration has approved the expansion of the use of the oral MS therapy Gilenya® (
fingolimod
, Novartis AG) to include the treatment of children and adolescents 10 years of age or older with relapsing MS.
bxrmom
in
My MSAA Community
6 years ago
New MS biomarker
Serum NfL levels were higher for patients starting natalizumab and rituximab compared with those starting interferon, glatiramer acetate, and
fingolimod
. The levels decreased over time with all of these treatments.
Serum NfL levels were higher for patients starting natalizumab and rituximab compared with those starting interferon, glatiramer acetate, and
fingolimod
. The levels decreased over time with all of these treatments.
erash
in
My MSAA Community
7 years ago
Filter results
Clear filters
Posted in
All communities
My MSAA Community
10 results
LUpus Patients Understanding and Support
1 result
Sort by
Most Relevant
Newest